Crossmark

Single-cell phenotypic profiling and backtracing exposes and predicts clinically relevant subpopulations in isogenic Staphylococcus aureus communities

Crossref DOI link: https://doi.org/10.1038/s42003-024-06894-z

Published Online: 2024-10-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hira, Jonathan

Singh, Bhupender

Halder, Tirthankar

Mahmutovic, Anel

Ajayi, Clement

Sekh, Arif Ahmed https://orcid.org/0000-0003-0706-2565
Hegstad, Kristin https://orcid.org/0000-0002-1314-0497
Johannessen, Mona

Lentz, Christian S. https://orcid.org/0000-0001-7284-2264
Funding

Funding for this research was provided by:

Helse Nord RHF (HNF1475-19)
License Information

Text and Data Mining valid from 2024-10-01

Version of Record valid from 2024-10-01
More Information

Article History

Received: 4 December 2023

Accepted: 13 September 2024

First Online: 1 October 2024

Competing interests

: The authors declare they have no competing interests. A.M. is an employee of Astra Zeneca. AstraZeneca did not have any influence on the design, execution, or analysis in this study.

Document is current

Any future updates will be listed below